Akebia Therapeutics任命生物制药领域领袖Philip Vickers博士加入董事会

美股速递
Apr 02

生物制药企业Akebia Therapeutics, Inc. (NASDAQ: AKBA) 宣布,正式任命行业资深专家Philip Vickers博士为公司董事会新成员。Vickers博士在生物医药研发及企业管理领域拥有深厚经验,他的加入预计将为公司战略发展及创新管线推进注入重要动能。此次人事变动即日生效,标志着Akebia Therapeutics在强化治理结构、吸纳跨界人才方面的持续布局。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10